Voyageur Pharmaceuticals (TSXV:VM) Change In Payables And Accrued Expense : C$0.54 Mil (TTM As of May. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Voyageur Pharmaceuticals Change In Payables And Accrued Expense?

Voyageur Pharmaceuticals's Change In Payables And Accrued Expense for the quarter that ended in May. 2024 was C$0.09 Mil. It means Voyageur Pharmaceuticals's Accounts Payable & Accrued Expense increased by C$0.09 Mil from Feb. 2024 to May. 2024 .

Voyageur Pharmaceuticals's Change In Payables And Accrued Expense for the fiscal year that ended in Nov. 2023 was C$0.07 Mil. It means Voyageur Pharmaceuticals's Accounts Payable & Accrued Expense increased by C$0.07 Mil from Nov. 2022 to Nov. 2023 .

Voyageur Pharmaceuticals Change In Payables And Accrued Expense Historical Data

The historical data trend for Voyageur Pharmaceuticals's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voyageur Pharmaceuticals Change In Payables And Accrued Expense Chart

Voyageur Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.15

0.17

-0.29

-0.19

0.07

Voyageur Pharmaceuticals Quarterly Data
	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-0.14	0.08	0.25	0.13	0.09

Voyageur Pharmaceuticals Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in May. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.54 Mil.

Voyageur Pharmaceuticals Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Voyageur Pharmaceuticals's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Voyageur Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Voyageur Pharmaceuticals Ltd (TSXV:VM) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

VYYRF:USA

Address

333 Southwest 7th Avenue, Suite 800, Calgary, AB, CAN, T2P 2Z1

Website

https://www.voyageurpharmaceuticals.ca

Voyageur Pharmaceuticals Ltd is engaged in the development of pharmaceutical ingredients (API) minerals. The company focuses on developing barium and iodine radiocontrast products and bromine-based pharmaceutical products. It provides its products for medical applications and diagnostics.

Executives

Charles Littlejohn

10% Security Holder

Voyageur Pharmaceuticals Headlines

No Headlines